SlideShare a Scribd company logo
Terry Kotrla, MS, MT(ASCP)BB
Unit 14 Quality Assurance in the
Transfusion Service
History of Regulation in Blood
Bank
 In the years before the HIV epidemic, blood
banks were perceived as organizations that
provided a community service
 Increased occurrence of HIV and increased
public scrutiny resulted in stricter FDA regulations
 FDA regulatory oversight has resulted in an
increased effort to provide a safe, high-quality
product at low cost
Overview
 Primary goal is transfusion of a safe unit of blood.
 To achieve quality must have:
 Well constructed SOPs.
 Well trained personnel who carefully adhere to
SOPs.
 Comprehensive guidelines in compliance with Joint
Commission, FDA, AABB and CAP.
 Failure in the quality of blood collected,
screening of collected blood or failure to follow
procedures in transfusion protocols may result
in fatal consequences.
Terms
 Quality control is the management of the testing process itself.
 Monitoring of equipment and instruments
 Determining that reagents are reacting appropriately.
 Quality Assurance includes the entire process of providing
patient care, from the time the physician orders the test until
treatment of patient based on results of test.
 Were appropriate lab tests ordered to determine the need for
transfusion.
 Did the transfusion service perform appropriate testing of patient
specimen and preparation of the appropriate component
 Was the transfusion administered properly.
 Did the patient obtain the anticipated benefit.
 Utilization review is the process of monitoring the
appropriateness of transfusion.
 Continuous quality improvement involves reviewing the
process of providing patient care with the goal of reducing
rework, waste and inappropriate care.
Good Manufacturing Practices
(cGMPs)
 cGMPs are legal requirements established by the
FDA
 These regulations specify what needs to be done
without specifying how it needs to be done
 The cGMPs are only a part of the overall quality
assurance (QA) program
Quality Assurance Program (QA)
 QA comprises the combined activities performed
by an organization
 Ensures the quality of products and services
offered
 Must include cGMPs
 Activities must be planned and documented by
written policies and procedures.
Records
 If it is not recorded it NEVER happened.
 Most common violation.
 Thorough record keeping essential.
 Recreates EVERY step related to production and distribution
of blood components including individuals involved.
 Creates an audit trail necessary to investigate errors.
 Original data CANNOT be obliterated, single line.
 Date and initial of changes required.
 NO white out or pencil is ever allowed.
 Document control essential as it specifies and describes:
media to be used, types of documents to keep and length
of time.
Audit Trail
 A thorough record-keeping system recreates
every step related to:
 Production
 Distribution of a unit of blood
 This step is known as an audit trail
 An audit trail is important when investigating
errors and accidents
 Ability to trace back to the original entry and
make corrections is also necessary in computer
systems.
Document Control
 Regulatory and accrediting agencies
expect documentation to be:
 Thorough
 Well organized
 Appropriately stored
 Retrievable in a reasonable amount of time
 Protected from unauthorized access
 Modification procedure in place
 Destruction procedure in place
Standard Operating Procedures
(SOP)
 All record systems, including their control,
handling, and disposal, must be thoroughly
described in the SOPs
 Describe how a particular task is to be
accomplished
 Are important training tools for new employees
 Are written using a standard format
Change Control
 The blood industry is in a constant state of
change
 Challenged routinely by new technologies and
regulatory and accrediting requirements
 Time consuming and requires money
 However, benefits outweigh costs
 Ensures that nothing “falls through the cracks
Personnel Qualifications
 Good employees are essential to the success of
any organization
 Hiring unqualified individuals can add significant
cost to the organization
 Selection process must be thorough, and minimal
pre-established criteria must be identified
 Job descriptions list the tasks for each individual
and are essential
 Once job is defined can then determine level of
education and training required.
Training
 A critical aspect of compliance with cGMPs
 Must define tasks performed and levels of
competence needed.
 Must have a written training program and
assessment to document and determine
competency of the employee.
 Review of SOPs
 Trainer's demonstration of tasks or procedure
 Employee’s performance with trainer’s assistance
 Employee’s performance without assistance
Competency Assessment
 When documented evidence exists that the
employee is able to demonstrate knowledge and
application of a new skill
 Initial competency assessment is done during
training
 Periodic competency is used to determine that
the employee has maintained the skill
Proof of Competency Requirements
 The following agencies have established
requirements for proof of competency for
personnel testing, twice the first year of
employment and annually thereafter:
 The Center for Medicare and Medicaid Services
 AABB
 CLIA
 Corrective actions needed for unacceptability
Proficiency Testing
 A required component of QA program
 Used to ensure that test methods and equipment are
working correctly
 Ensures that staff members are following procedures
 Assigning external proficiency testing samples on a
rotating basis.
 Proficiency testing may be internal, external or both.
 Observing employee performing assigned tasks.
 Reviewing documentation.
 Internal - Unknown samples prepared in house
 External - CAP survey is one example
 Written exams.
 Corrective action is implemented and monitored for
improvement when results are not acceptable
Supplier Qualifications
 The quality of any given product is as good as the
quality of the raw materials
 Supplier qualification has become standard
practice in blood banks
 Written agreements between blood banks and
suppliers are common practice
 Specific terms of product expectations
 Course of action when criteria are not met
Error Management
 Part of a QA plan must include mechanisms for
the detection and management of errors and their
consequences
 Errors, incidents, variances, and any
nonconformance should be documented and
investigated
 Employees must involved in all aspects
 Root-cause analysis should be initiated
Recalls
 FDA requires that licensed and registered
facilities report any incidences of an error or
accident
 If the investigation reveals that the root cause
was due to an error in manufacturing, a recall
may take place
 Recalls are usually issued by manufacturers in an
attempt to remove products from the market
Validation
 A process that establishes documented evidence
providing a high degree of assurance that a
specific product meets its pre-established quality
and performance specifications
 Validation necessitates the commitment of time,
resources, and manpower
 Must be planned and thoroughly documented
Facilities and Equipment
 Facilities and equipment should be designed in compliance
and support of cGMPs
 Documentation must be made of routine maintenance,
repairs and testing performed on instruments from date of
receipt to date instrument is permanently removed from
service.
 Temperature monitoring is critical for refrigerators,
freezers, incubators and waterbaths.
 Must be manually recorded daily.
 Refrigerators and freezers must have a device to record the
temperature 24 hours a day.
 When temperature is out of range must have documentation of
reason or corrective action taken.
 Alarms on refrigerators and freezers must be tested
periodically to make sure they will sound at the appropriate
temperature.
Quality Assessment of Supplies and
Reagents
 The following reagents must be tested each day of
use:
 antihuman globulin serum
 blood grouping anti-serums
 lectins
 antibody screening cells
 reverse grouping cells
 Enzymes
 For donor collection facilities the following must be
tested with each run:
 hepatitis testing reagents
 HIV testing reagents
 HTLV-I/II reagents
 ALT testing reagents
 syphilis serology reagents.
Quality Assessment of Supplies and
Reagents
 When reagents and supplies are received each of
the following must be documented during the log
in process:
 date of receipt
 manufacturer
 lot number
 expiration date
 review of manufacturer's circular for changes
 leaking or damaged containers
Quality Assessment of Supplies and
Reagents
 Before being placed in use reagents are
tested for sensitivity and specificity.
 Daily testing is required to ensure the reagent
has not lost potency or reactivity.
 Can use a formand procedure created in-house or
utilize QC kit provided by a manufacturer.
 Lot numbers and expiration date of all reagents
tested must be on the form.
 Graded reactions recorded.
 Special typing sera need only be QCd when used.
 Final disposition of damaged or unsatisfactory
reagents must be documented.
Other Issues
 Lot release and label control to avoid product
recall resulting from mislabeling
 QA department to coordinate all activities related
to QA
 Regulatory agencies include AABB and FDA;
their compliance standards should be known
 International Standards Organization 9000
provides guidance in the development of
standards; not specific for any product or industry
Quality Assessment and Utilization
Review
 Most facilities use the 10 step process outlined by
Joint Commission
 Assign responsibility
 Delineate the scope of care
 Identify the most important aspect of care
 Identify indicators
 Establish thresholds
 Collect and organize data
 Evaluate data
 Take corrective action
 Assess actions and document improvement
 Communicate.
Transfusion Committee
 Medical staff responsible for assessing adequacy
of transfusion services and proper use of blood
components.
 Reviews usage of all components for
appropriateness.
 Reviews records of all transfusion reactions.
 Reviews order practices.
Utilization Review
 Required by Joint Commission
 Used to assess the blood ordering and
transfusion practices of the medical staff.
 Crossmatch:transfusion ratio
 Number of units crossmatched divided by the actual
number transfused.
 Used as an indicator that too much blood is being
requested to be on hold.
 Could result in high outdate or waste.
 Number of autologous transfusions.
Utilization Review
 Number of emergency releases.
 Calculate statistics by physician.
 Review of records to determine if transfusion was
justified.
 Audit criteria for transfusion must be defined:
 Hematocrit less than 24%
 Hemoglobin of less than 8 gm/dL
 Symptoms due to anemia
 Recent estimated blood loss of greater than 10% of
total blood volume.
 If audit reveals unjustified transfusion physician is
notified and asked to respond.
Reference:
 Basic & Applied Concepts of Immunohematology,
2nd edition, Blaney.
 Guide to the preparation, use and quality
assurance of blood components, 7th edition,
Council of Europe Publishing
 Technical Manual American Association of Blood
Banks, 11th edition
 Quality Assurance in Blood Transfusion Service
http://www.bloodindex.net/quality_asssurance_intro.php

More Related Content

Similar to bb_unit15QualityAssuranceTransfusionServiceSpring2011 (1).ppt

Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
MadhavMady3
 
Lecture 2: QA and Qc in Pharma Industry
Lecture 2: QA and Qc in Pharma IndustryLecture 2: QA and Qc in Pharma Industry
Lecture 2: QA and Qc in Pharma Industry
Sapan Shah
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
Atul Adhikari
 
Qualification and validation
Qualification and validationQualification and validation
Qualification and validation
Archana Mandava
 
Good Manufacturing Practices (GMP)- Purpose and Principles
Good Manufacturing Practices (GMP)- Purpose and PrinciplesGood Manufacturing Practices (GMP)- Purpose and Principles
Good Manufacturing Practices (GMP)- Purpose and Principles
Imran Malik
 
Pharmaceutical Validation
Pharmaceutical Validation Pharmaceutical Validation
Pharmaceutical Validation
shubhamgharat3
 
Raw Material Validation
Raw Material ValidationRaw Material Validation
Raw Material Validation
Hiron Devnath
 
BMT GxP Training 10-22-2021 1.pptx
BMT GxP Training 10-22-2021 1.pptxBMT GxP Training 10-22-2021 1.pptx
BMT GxP Training 10-22-2021 1.pptx
haploidentical
 
Pharmaceutical Validation ( As per M.Pharm 1st sem Syllabus).pptx
Pharmaceutical Validation ( As per M.Pharm 1st sem Syllabus).pptxPharmaceutical Validation ( As per M.Pharm 1st sem Syllabus).pptx
Pharmaceutical Validation ( As per M.Pharm 1st sem Syllabus).pptx
MariaSaifee
 
Quality
QualityQuality
Quality
Naman Gupta
 
Audits
AuditsAudits
Audits
Swathi P
 
Introduction To Qaqc
Introduction To QaqcIntroduction To Qaqc
Introduction To QaqcSAIKATGHOSH58
 
Pharmaceutical validation , Types of validation
Pharmaceutical validation , Types of validationPharmaceutical validation , Types of validation
Pharmaceutical validation , Types of validation
thekhajaaneesahmed78
 
VALIDATION BY DHIRAJ SHRESTHA
VALIDATION BY DHIRAJ SHRESTHAVALIDATION BY DHIRAJ SHRESTHA
VALIDATION BY DHIRAJ SHRESTHA
Dhiraj Shrestha
 
Quality Audit
Quality AuditQuality Audit
Quality Audit
ClinosolIndia
 
GMP compliances of Audit
GMP compliances of AuditGMP compliances of Audit
GMP compliances of Audit
Megha bhise
 
Quality assurance and quality management concepts.pptx
Quality assurance and quality management concepts.pptxQuality assurance and quality management concepts.pptx
Quality assurance and quality management concepts.pptx
GayatriBahatkar1
 
Validation ppt nikita
Validation ppt nikitaValidation ppt nikita
Validation ppt nikita
NikitaNikam8
 
Gmp Guidelines by HCP
Gmp Guidelines by HCPGmp Guidelines by HCP
Gmp Guidelines by HCP
Atlantic Training, LLC.
 
Medical Device Registration in India_ A Comprehensive Guide.pdf
Medical Device Registration in India_ A Comprehensive Guide.pdfMedical Device Registration in India_ A Comprehensive Guide.pdf
Medical Device Registration in India_ A Comprehensive Guide.pdf
PranshuCorpseed
 

Similar to bb_unit15QualityAssuranceTransfusionServiceSpring2011 (1).ppt (20)

Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
 
Lecture 2: QA and Qc in Pharma Industry
Lecture 2: QA and Qc in Pharma IndustryLecture 2: QA and Qc in Pharma Industry
Lecture 2: QA and Qc in Pharma Industry
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
 
Qualification and validation
Qualification and validationQualification and validation
Qualification and validation
 
Good Manufacturing Practices (GMP)- Purpose and Principles
Good Manufacturing Practices (GMP)- Purpose and PrinciplesGood Manufacturing Practices (GMP)- Purpose and Principles
Good Manufacturing Practices (GMP)- Purpose and Principles
 
Pharmaceutical Validation
Pharmaceutical Validation Pharmaceutical Validation
Pharmaceutical Validation
 
Raw Material Validation
Raw Material ValidationRaw Material Validation
Raw Material Validation
 
BMT GxP Training 10-22-2021 1.pptx
BMT GxP Training 10-22-2021 1.pptxBMT GxP Training 10-22-2021 1.pptx
BMT GxP Training 10-22-2021 1.pptx
 
Pharmaceutical Validation ( As per M.Pharm 1st sem Syllabus).pptx
Pharmaceutical Validation ( As per M.Pharm 1st sem Syllabus).pptxPharmaceutical Validation ( As per M.Pharm 1st sem Syllabus).pptx
Pharmaceutical Validation ( As per M.Pharm 1st sem Syllabus).pptx
 
Quality
QualityQuality
Quality
 
Audits
AuditsAudits
Audits
 
Introduction To Qaqc
Introduction To QaqcIntroduction To Qaqc
Introduction To Qaqc
 
Pharmaceutical validation , Types of validation
Pharmaceutical validation , Types of validationPharmaceutical validation , Types of validation
Pharmaceutical validation , Types of validation
 
VALIDATION BY DHIRAJ SHRESTHA
VALIDATION BY DHIRAJ SHRESTHAVALIDATION BY DHIRAJ SHRESTHA
VALIDATION BY DHIRAJ SHRESTHA
 
Quality Audit
Quality AuditQuality Audit
Quality Audit
 
GMP compliances of Audit
GMP compliances of AuditGMP compliances of Audit
GMP compliances of Audit
 
Quality assurance and quality management concepts.pptx
Quality assurance and quality management concepts.pptxQuality assurance and quality management concepts.pptx
Quality assurance and quality management concepts.pptx
 
Validation ppt nikita
Validation ppt nikitaValidation ppt nikita
Validation ppt nikita
 
Gmp Guidelines by HCP
Gmp Guidelines by HCPGmp Guidelines by HCP
Gmp Guidelines by HCP
 
Medical Device Registration in India_ A Comprehensive Guide.pdf
Medical Device Registration in India_ A Comprehensive Guide.pdfMedical Device Registration in India_ A Comprehensive Guide.pdf
Medical Device Registration in India_ A Comprehensive Guide.pdf
 

Recently uploaded

Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 

Recently uploaded (20)

Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 

bb_unit15QualityAssuranceTransfusionServiceSpring2011 (1).ppt

  • 1. Terry Kotrla, MS, MT(ASCP)BB Unit 14 Quality Assurance in the Transfusion Service
  • 2. History of Regulation in Blood Bank  In the years before the HIV epidemic, blood banks were perceived as organizations that provided a community service  Increased occurrence of HIV and increased public scrutiny resulted in stricter FDA regulations  FDA regulatory oversight has resulted in an increased effort to provide a safe, high-quality product at low cost
  • 3. Overview  Primary goal is transfusion of a safe unit of blood.  To achieve quality must have:  Well constructed SOPs.  Well trained personnel who carefully adhere to SOPs.  Comprehensive guidelines in compliance with Joint Commission, FDA, AABB and CAP.  Failure in the quality of blood collected, screening of collected blood or failure to follow procedures in transfusion protocols may result in fatal consequences.
  • 4. Terms  Quality control is the management of the testing process itself.  Monitoring of equipment and instruments  Determining that reagents are reacting appropriately.  Quality Assurance includes the entire process of providing patient care, from the time the physician orders the test until treatment of patient based on results of test.  Were appropriate lab tests ordered to determine the need for transfusion.  Did the transfusion service perform appropriate testing of patient specimen and preparation of the appropriate component  Was the transfusion administered properly.  Did the patient obtain the anticipated benefit.  Utilization review is the process of monitoring the appropriateness of transfusion.  Continuous quality improvement involves reviewing the process of providing patient care with the goal of reducing rework, waste and inappropriate care.
  • 5. Good Manufacturing Practices (cGMPs)  cGMPs are legal requirements established by the FDA  These regulations specify what needs to be done without specifying how it needs to be done  The cGMPs are only a part of the overall quality assurance (QA) program
  • 6.
  • 7. Quality Assurance Program (QA)  QA comprises the combined activities performed by an organization  Ensures the quality of products and services offered  Must include cGMPs  Activities must be planned and documented by written policies and procedures.
  • 8.
  • 9. Records  If it is not recorded it NEVER happened.  Most common violation.  Thorough record keeping essential.  Recreates EVERY step related to production and distribution of blood components including individuals involved.  Creates an audit trail necessary to investigate errors.  Original data CANNOT be obliterated, single line.  Date and initial of changes required.  NO white out or pencil is ever allowed.  Document control essential as it specifies and describes: media to be used, types of documents to keep and length of time.
  • 10. Audit Trail  A thorough record-keeping system recreates every step related to:  Production  Distribution of a unit of blood  This step is known as an audit trail  An audit trail is important when investigating errors and accidents  Ability to trace back to the original entry and make corrections is also necessary in computer systems.
  • 11.
  • 12. Document Control  Regulatory and accrediting agencies expect documentation to be:  Thorough  Well organized  Appropriately stored  Retrievable in a reasonable amount of time  Protected from unauthorized access  Modification procedure in place  Destruction procedure in place
  • 13. Standard Operating Procedures (SOP)  All record systems, including their control, handling, and disposal, must be thoroughly described in the SOPs  Describe how a particular task is to be accomplished  Are important training tools for new employees  Are written using a standard format
  • 14.
  • 15. Change Control  The blood industry is in a constant state of change  Challenged routinely by new technologies and regulatory and accrediting requirements  Time consuming and requires money  However, benefits outweigh costs  Ensures that nothing “falls through the cracks
  • 16.
  • 17. Personnel Qualifications  Good employees are essential to the success of any organization  Hiring unqualified individuals can add significant cost to the organization  Selection process must be thorough, and minimal pre-established criteria must be identified  Job descriptions list the tasks for each individual and are essential  Once job is defined can then determine level of education and training required.
  • 18. Training  A critical aspect of compliance with cGMPs  Must define tasks performed and levels of competence needed.  Must have a written training program and assessment to document and determine competency of the employee.  Review of SOPs  Trainer's demonstration of tasks or procedure  Employee’s performance with trainer’s assistance  Employee’s performance without assistance
  • 19. Competency Assessment  When documented evidence exists that the employee is able to demonstrate knowledge and application of a new skill  Initial competency assessment is done during training  Periodic competency is used to determine that the employee has maintained the skill
  • 20. Proof of Competency Requirements  The following agencies have established requirements for proof of competency for personnel testing, twice the first year of employment and annually thereafter:  The Center for Medicare and Medicaid Services  AABB  CLIA  Corrective actions needed for unacceptability
  • 21. Proficiency Testing  A required component of QA program  Used to ensure that test methods and equipment are working correctly  Ensures that staff members are following procedures  Assigning external proficiency testing samples on a rotating basis.  Proficiency testing may be internal, external or both.  Observing employee performing assigned tasks.  Reviewing documentation.  Internal - Unknown samples prepared in house  External - CAP survey is one example  Written exams.  Corrective action is implemented and monitored for improvement when results are not acceptable
  • 22. Supplier Qualifications  The quality of any given product is as good as the quality of the raw materials  Supplier qualification has become standard practice in blood banks  Written agreements between blood banks and suppliers are common practice  Specific terms of product expectations  Course of action when criteria are not met
  • 23. Error Management  Part of a QA plan must include mechanisms for the detection and management of errors and their consequences  Errors, incidents, variances, and any nonconformance should be documented and investigated  Employees must involved in all aspects  Root-cause analysis should be initiated
  • 24. Recalls  FDA requires that licensed and registered facilities report any incidences of an error or accident  If the investigation reveals that the root cause was due to an error in manufacturing, a recall may take place  Recalls are usually issued by manufacturers in an attempt to remove products from the market
  • 25. Validation  A process that establishes documented evidence providing a high degree of assurance that a specific product meets its pre-established quality and performance specifications  Validation necessitates the commitment of time, resources, and manpower  Must be planned and thoroughly documented
  • 26. Facilities and Equipment  Facilities and equipment should be designed in compliance and support of cGMPs  Documentation must be made of routine maintenance, repairs and testing performed on instruments from date of receipt to date instrument is permanently removed from service.  Temperature monitoring is critical for refrigerators, freezers, incubators and waterbaths.  Must be manually recorded daily.  Refrigerators and freezers must have a device to record the temperature 24 hours a day.  When temperature is out of range must have documentation of reason or corrective action taken.  Alarms on refrigerators and freezers must be tested periodically to make sure they will sound at the appropriate temperature.
  • 27. Quality Assessment of Supplies and Reagents  The following reagents must be tested each day of use:  antihuman globulin serum  blood grouping anti-serums  lectins  antibody screening cells  reverse grouping cells  Enzymes  For donor collection facilities the following must be tested with each run:  hepatitis testing reagents  HIV testing reagents  HTLV-I/II reagents  ALT testing reagents  syphilis serology reagents.
  • 28. Quality Assessment of Supplies and Reagents  When reagents and supplies are received each of the following must be documented during the log in process:  date of receipt  manufacturer  lot number  expiration date  review of manufacturer's circular for changes  leaking or damaged containers
  • 29. Quality Assessment of Supplies and Reagents  Before being placed in use reagents are tested for sensitivity and specificity.  Daily testing is required to ensure the reagent has not lost potency or reactivity.  Can use a formand procedure created in-house or utilize QC kit provided by a manufacturer.  Lot numbers and expiration date of all reagents tested must be on the form.  Graded reactions recorded.  Special typing sera need only be QCd when used.  Final disposition of damaged or unsatisfactory reagents must be documented.
  • 30. Other Issues  Lot release and label control to avoid product recall resulting from mislabeling  QA department to coordinate all activities related to QA  Regulatory agencies include AABB and FDA; their compliance standards should be known  International Standards Organization 9000 provides guidance in the development of standards; not specific for any product or industry
  • 31. Quality Assessment and Utilization Review  Most facilities use the 10 step process outlined by Joint Commission  Assign responsibility  Delineate the scope of care  Identify the most important aspect of care  Identify indicators  Establish thresholds  Collect and organize data  Evaluate data  Take corrective action  Assess actions and document improvement  Communicate.
  • 32. Transfusion Committee  Medical staff responsible for assessing adequacy of transfusion services and proper use of blood components.  Reviews usage of all components for appropriateness.  Reviews records of all transfusion reactions.  Reviews order practices.
  • 33. Utilization Review  Required by Joint Commission  Used to assess the blood ordering and transfusion practices of the medical staff.  Crossmatch:transfusion ratio  Number of units crossmatched divided by the actual number transfused.  Used as an indicator that too much blood is being requested to be on hold.  Could result in high outdate or waste.  Number of autologous transfusions.
  • 34. Utilization Review  Number of emergency releases.  Calculate statistics by physician.  Review of records to determine if transfusion was justified.  Audit criteria for transfusion must be defined:  Hematocrit less than 24%  Hemoglobin of less than 8 gm/dL  Symptoms due to anemia  Recent estimated blood loss of greater than 10% of total blood volume.  If audit reveals unjustified transfusion physician is notified and asked to respond.
  • 35. Reference:  Basic & Applied Concepts of Immunohematology, 2nd edition, Blaney.  Guide to the preparation, use and quality assurance of blood components, 7th edition, Council of Europe Publishing  Technical Manual American Association of Blood Banks, 11th edition  Quality Assurance in Blood Transfusion Service http://www.bloodindex.net/quality_asssurance_intro.php